Hidradenitis Suppurativa (HS)

Hidradenitis Suppurativa (HS) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as: Hidradenitis Suppurativa
Classified under: Immune System Diseases
Physiological and Biological Processes
Signs, Symptoms, and General Pathologies
Skin and Subcutaneous Tissue Diseases
Indicated drugs: Adalimumab
Neomycin

Resolves to

Vocabularies

MeSHM0026548ICD-10L73.2SNOMED CT156417004MedDRA10020040UMLSC0085160

What you can answer from here — as of September 30, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

182Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Hidradenitis Suppurativa (HS) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.